North Run Capital, LP Stereotaxis, Inc. Call Options Transaction History
North Run Capital, LP
- $43 Million
- Q4 2022
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding STXS
# of Institutions
88Shares Held
41.6MCall Options Held
86.5KPut Options Held
43.2K-
Dafna Capital Management LLC Los Angeles, CA13.7MShares$24.1 Million8.6% of portfolio
-
Lagoda Investment Management, L.P. New York, NY3.83MShares$6.74 Million6.2% of portfolio
-
Redmile Group, LLC San Francisco, CA3.31MShares$5.82 Million0.34% of portfolio
-
Arbiter Partners Capital Management LLC New York, NY2.76MShares$4.85 Million11.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.61MShares$4.6 Million0.0% of portfolio
About Stereotaxis, Inc.
- Ticker STXS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 74,790,096
- Market Cap $132M
- Description
- Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by pr...